Pharmacology
-
Hamm’s research honored by Dutch pharmacology society
Heidi Hamm, Ph.D., chair of the Department of Pharmacology, has won the 2012 Ariens Award from the Dutch Pharmacological Society. Read MoreOct 25, 2012
-
Targeting new pathways to ease pain
The spinal cord’s neuropeptide Y signaling pathway may be a good target for new pain therapeutics. Read MoreAug 30, 2012
-
Clues to retinal cell degeneration
A reversible chemical modification of rhodopsin, a receptor for light, plays a role in the degeneration of retinal cells. Read MoreAug 28, 2012
-
VU, Lipscomb partner on dual degree program
A new cooperative program between Vanderbilt University and Lipscomb University’s College of Pharmacy is focusing on the next generation of pharmaceutical researchers. By offering a pathway for students to earn both Pharm.D. and Ph.D. degrees, the program aims to boost the number of pharmacy-trained research scientists. Read MoreAug 23, 2012
-
Key to a woman’s heart (condition)?
Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity. Read MoreAug 10, 2012
-
Biomarkers may offer autism clues
A combination of biomarkers may reveal new clues about causes of and potential interventions for autism. Read MoreJul 31, 2012
-
Vanderbilt-led team to develop ‘microbrain’ to improve drug testing
Creating a device out of human cells that simulates brain chemistry is the goal of a $6.4 million grant which is part of major new federal initiative to develop a series of “organs on a chip” designed to improve the drug development process. Read MoreJul 24, 2012
-
VU study finds stress fuels breast cancer metastasis to bone
Stress can promote breast cancer cell colonization of bone, Vanderbilt Center for Bone Biology investigators have discovered. Read MoreJul 18, 2012
-
Insights for neuroscience drug discovery
When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects. Read MoreJul 17, 2012
-
Probing the roots of depression by tracking serotonin regulation at a new level
An interdisciplinary team of scientists have successfully tagged a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of individual molecules for the first time. This capability makes it possible to study the manner in which serotonin regulates mood, appetite and sleep at a new level of detail. Read MoreJun 27, 2012
-
Vanderbilt identifies genes linked to breast cancer chemo resistance
A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer. Read MoreJun 11, 2012
-
Common antibiotic found to pose increased heart risk
Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a “Z-pack.” The study found a 2.5-fold higher risk of death from cardiac arrhythmia in the first five days of taking azithromycin when compared with another common antibiotic or no antibiotics at all. Read MoreMay 21, 2012
-
New clue to ADHD
A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD. Read MoreMay 15, 2012
-
Probing epilepsy’s molecular sparks
Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies. Read MoreMay 10, 2012
-
Minds wide open: Neuroscience at Vanderbilt
Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience. Read MoreApr 6, 2012
-
Mouse model for autism yields clues to a 50-year-old mystery
A genetic variation that causes early disruptions in serotonin signaling in the brain may contribute to autism spectrum disorder and other enduring effects on behavior. Read MoreMar 20, 2012
-
Vanderbilt expanding research enterprise into Williamson County
With the addition of a new 18,000-square-foot laboratory to be located within the Cool Springs Life Sciences Center, Vanderbilt University is expanding its research enterprise into Williamson County. Read MoreMar 9, 2012
-
Combo combats dizziness
Some patients may need a combo of medications to combat a condition that causes dizziness. Read MoreMar 9, 2012
-
VU researcher has personal motive for investigating malaria
Vanderbilt researcher and Gabon, Africa, native is working to discover ways to kill malaria-spreading mosquitoes. Read MoreFeb 3, 2012
-
Pumping up the pancreas in pregnancy
A strain of mutant mice provide a novel model for studying glucose intolerance and gestational diabetes during pregnancy and suggest that certain molecules may be useful for therapeutic applications. Read MoreJan 20, 2012